The global Lactoferrin Market is expected to reach a market valuation of USD 247.0 million in 2023, recording a CAGR of 4.7% from 2023 to 2033. Overall lactoferrin sales are slated to surge at a robust pace during the assessment period, taking the market valuation to USD 711.9 million by 2033.
Demand for lactoferrin is anticipated to increase as consumers become more conscious of their nutrition and general health, as well as skin-related illnesses becoming more common.
Lactoferrin, also referred to as lactotransferrin, is a powerful multifunctional protein found in several secretory fluids including milk, tears, and nasal secretions. It is being increasingly utilized in applications such as nutraceutical, food nutrition, infant formula, and clinical nutrition due to its antibacterial, antiviral, antifungal, and anticarcinogenic activities.
Growing awareness among the general population about the health benefits of lactoferrin and widening application area will boost the global lactoferrin industry during the projection period.Increased spending on functional and healthy foods that help boost the immune system is expected to fuel lactoferrin sales over the assessment period.
Similarly, rising prevalence of skin conditions such as acne and increasing demand for effective treatments for these conditions are likely to elevate lactoferrin demand between 2023 and 2033.
The efficacy of lactoferrin in treating acne and other skin disorders has been demonstrated in numerous clinical studies. The main source of sustenance for infections is eliminated by lactoferrin by neutralizing its contributions owing to its anti-inflammatory capabilities.Over the projection period, it is anticipated that the increasing incidence of acne in developed countries such as the USA and Germany, would open up new growth opportunities for product makers.
Another significant factor influencing the growth of the lactoferrin market is the increase in the use of lactoferrin by the pharmaceutical industry.
The lactoferrin market will continue to benefit from lucrative growth prospects brought on by the increasing use of lactoferrin in cosmetic products around the world.
| Attributes | Key Insights |
|---|---|
| Lactoferrin Market Estimated Value (2023) | USD 247.0 million |
| Projected Market Value (2033) | USD 711.0 million |
| Value-based CAGR (2023 to 2033) | 4.7% |
| Top 3 Countries’ Market Share | 23.0% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to Future Market Insights, global sales of lactoferrin witnessed a steady CAGR during the historical period from 2018 to 2022. For the projection period (2023 and 2033), lactoferrin demand is forecast to rise at a steady CAGR of 4.7%.Increasing application of lactoferrin in dietary supplements, infant formulas, clinical nutrition, and others is a key factor driving the global lactoferrin market forward.
Due to its potent health advantages, lactoferrin is becoming increasingly incorporated into a variety of product categories, such as infant food, nutritional supplements, dietetic foods, alcoholic drinks, sports nutrition, hygiene products, and cosmetics. This will generate a significant amount of growth opportunities for lactoferrin manufacturers during the forecast period.
Medical conditions such as hepatitis C infection, anemia, and diarrhea can be successfully treated with lactoferrin. For instance, by regulating iron metabolism, lactoferrin has immune system-stimulating effects, which protect against aging-related cell damage, encourage the growth of healthy bacteria in the intestines, and regulate viruses, bacteria, and fungi.
Hence, growing awareness about the potential health benefits of lactoferrin and widening applications in pharmaceutical and clinical nutrition will generate sizable prospects for market expansion.Similarly, incorporation of lactoferrin in infant nutrition is expected to boost lactoferrin sales during the next ten years. To promote babies' general health, lactoferrin is extensively used in infant formulas.
Only 27% of infants worldwide are breastfed, according to recent research by the World Health Organization (WHO), which has led to infant vitamin deficiencies. Therefore, healthful and vital supplements such as lactoferrin are used in newborn formulations, which is anticipated to help the lactoferrin market develop.
Regionally, Asia Pacific is anticipated to expand at a CAGR of about 4.3% during the projection period. Lactoferrin's health advantages are widely known in nations such as China and Japan, and Australia, which is anticipated to support market expansion during the assessment period.
Growing Demand for High Nutritional Supplements Driving Lactoferrin Sales in Australia
According to Future Market Insights, sales of lactoferrin across Australia are projected to rise at a significant pace during the projection period owing to the rising demand for high nutritional supplements.Australia is quickly becoming a prominent market for lactoferrin in Oceania due to its consistent milk supply, which is carefully regulated by cutting-edge manufacturing facilities and food standard codes.
Manufacturers are releasing several lactoferrin supplements and nutraceuticals for women, children, and teenagers while getting components from nearby areas. This is anticipated to accelerate the demand for lactoferrin, creating profitable opportunities for lactoferrin manufacturers.
Growing Demand for Next-Generation Infant Formulas Driving Market in China
Currently, China holds a prominent share of East Asia lactoferrin market and it is poised to exhibit healthy growth during the next ten years. This is attributed to rising usage of lactoferrin in infant formulas, strong presence of leading lactoferrin manufacturing companies, and favorable government support.
In 2008, a devastating milk scandal shook China, which left 300000 children and infants ill and at least 6 dead. Since then, consumers are looking for high-quality infant nourishment items. This has prompted infant formula manufacturers to use healthy and nutritional ingredients such as lactoferrin in their products.
Similarly, sales of lactoferrin in China will be driven by awareness campaigns and promotional activities that highlight the advantages of this natural protein supplement.
Principal Consultant
Powdered Lactoferrin holds a Lion’s Share in the Market
Based on form, the global market for lactoferrin is segmented into powder and liquid. Among these, powdered lactoferrin segment held around 88.9% share of the global market and it is expected to retain its dominance during the projection period.Growing usage of powdered lactoferrin in a wide range of applications due to its longer shelf life and convenient nature is a key factor driving growth of the target segment.
End users prefer powdered lactoferrin as its shelf life is more when compared to the liquid form. It is also easy to store and lasts a little longer. Hence, various attractive features of powdered lactoferrin will continue to encourage its adoption across industries during the projection period.
Clinical Nutrition to Generate Maximum Opportunities for Lactoferrin Manufacturers
According to Future market insights, the infant formulas segment holds a significant share of around 36.9% of the global market. This is attributed to rising prevalence of malnutrition among infants and children and increasing clinal studies supporting the integration of lactoferrin in infant nutrition.
However, the clinical nutrition segment is anticipated to expand at a robust CAGR of 7.3% between 2023 and 2033, generating significant revenues by the end of 2033. This is due to rising usage of lactoferrin for making clinical nutrition due to its antioxidant, anti-inflammatory, antibacterial, and antiviral properties.
Vitalus Nutrition Inc., Glanbia plc, Milei Gmbh, NutriScience, Nestle SA, Pharming Group NV, Farbest Brands, Bega Cheese Group, Fonterra Co-operative Group Ltd, and InVitria are identified as key players in the lactoferrin industry.Manufacturers are attempting to use research and technological advancements to enter or strengthen their position in new markets. For instance:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attribute | Details |
|---|---|
| Estimated Market Size (2023) | USD 247.0 million |
| Projected Market Size (2033) | USD 711.0 million |
| Anticipated Growth Rate (2023 to 2033) | 4.7% CAGR |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD million for Value and MT for Volume |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Germany, United Kingdom, France, Italy, Spain, Nordic, Russia, Poland, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Singapore, Australia, New Zealand, GCC countries, North Africa, South Africa, others. |
| Key Segments Covered | Form, Application, and Region |
| Key Companies Profiled | Pharming Group NV; Synlait Milk Ltd.; Metagenics Inc.,; MP Biomedicals; Westland Cooperative Dairy Co.Ltd.; APS BioGroup; Glanbia plc; Farbest Brands; Milei GmbH; Fonterra Cooperative Group Ltd.; InVitria Hoogwegt Group B.V.; Bega Cheese Limited; Ferrin-Tech LLC; Others |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
The global lactoferrin market size is estimated to be valued at USD 247.0 million in 2023.
Between 2023 and 2033, lactoferrin demand is forecast to surge at 4.7% CAGR.
As per FMI, the global lactoferrin industry is projected to reach a valuation of USD 711.9 million by 2033.
Clinical nutrition segment is expected to generate maximum growth opportunities for the manufacturers of lactoferrin.
Key players in the market are Hilmar Cheese Company, Pharming Group NV, FrieslandCampina, Synlait Milk Ltd., Ingredia SA, MP Biomedicals, Tatura Milk Industries Ltd., Glanbia plc, APS BioGroup, ProHealth, Fonterra Cooperative Group Ltd., Farbest Brands, InVcmbH, and Ferrin-tech LLC.
The market is valued at USD 247 million in 2023.
The market’s CAGR from 2023 to 2033 is estimated to be 4.7%.
The top three countries hold a share of 23% of the market.
China, India, and Australia are projected to expand the demand.
Infant formulas are likely to hold a 36.9% share of the market.
1. Executive Summary | Lactoferrin Market 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Form 5.1. Powder 5.2. Liquid 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Sports Nutrition 6.2. Infant Formulas 6.3. Clinical Nutrition 6.4. Veterinary Nutrition 6.5. Personal Care 6.6. Food Nutrition 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. North America 7.2. Latin America 7.3. Europe 7.4. East Asia 7.5. South Asia 7.6. Oceania 7.7. Middle East & Africa 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Middle East & Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Key Countries Market Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1. Glanbia plc 17.2. Vitalus Nutrition Inc. 17.3. Pharming Group NV 17.4. Nestle SA 17.5. Danisco A/S 17.6. Farbest Brands 17.7. InVitria 17.8. Fonterra Co-operative Group Ltd. 17.9. Bega Cheese Group 17.10. Milei GMBH 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Food and Beverage Insights
View Reports
Lactoferrin Market
